WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 心室性期外収縮の臨床的意義および治療 clinical significance and treatment of ventricular premature beats
2. 明らかな器質的心疾患のない患者の非持続性心室性頻拍 nonsustained vt in the absence of apparent structural heart disease
3. 心室性期外収縮の有病割合および評価 prevalence and evaluation of ventricular premature beats
4. 非持続性心室頻拍のマネージメント management of nonsustained ventricular tachycardia
5. I群抗不整脈薬の主な副作用 major side effects of class i antiarrhythmic drugs

Embozene™ microspheres induced nonreperfused myocardial infarction in an experimental swine model.

Varga-Szemes A, Kiss P, Brott BC, Wang D, Simor T, Elgavish GA.SourceDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama; Elgavish Paramagnetics Inc., Birmingham, Alabama; Heart Institute, Medical School, University of Pecs, Hungary.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.Catheter Cardiovasc Interv.2013 Mar;81(4):689-97. doi: 10.1002/ccd.24418. Epub 2012 May 4.
OBJECTIVES: To develop a magnetic resonance imaging (MRI) compatible, percutaneous technique for the generation of nonreperfused myocardial infarct (MI).BACKGROUND: Modeling nontreated MI has major importance in the development and preclinical testing of new therapeutic strategies for patients missi
PMID 22431438

Steriotis AK, Nava A, Rigato I, Mazzotti E, Daliento L, Thiene G, Basso C, Corrado D, Bauce B.SourceDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy. Electronic address: steriotis@hotmail.com.
The American journal of cardiology.Am J Cardiol.2013 Feb 15;111(4):557-62. doi: 10.1016/j.amjcard.2012.10.044. Epub 2012 Dec 6.
The aim of this study was to analyze using noninvasive cardiac examinations a series of young athletes discovered to have ventricular arrhythmias (VAs) during the preparticipation screening program for competitive sports. One hundred forty-five athletes (mean age 17 ± 5 years) were evaluated. The s
PMID 23219000

Small Left Atrial Diameter Is a Predictor of Ectopy from Superior Vena Cava in Patients with Atrial Fibrillation

Wada Mitsuru,Hirata Akio,Nakanishi Hiroyuki,Kashiwase Kazunori,Ueda Yasunori
Journal of Arrhythmia 27(Supplement), OP19_1, 2011
… Ectopy from superior vena cava (SVC) is frequently seen, and it is treatable by SVC isolation. … We investigated pre-procedure predictors of SVC ectopy. … After pulmonary vein isolation (isolation of all 4 pulmonary veins), we induced supra-ventricular ectopies initiating AF by infusion of isoproterenol (2–5 µg/min) and identified their originating sites. … SVC ectopy was induced in 9 (9%) of patients. …
NAID 130002129855

海外では上室性頻拍の薬物治療として用いられる。日本ではATPが用いられる。(用量：ATP 10mg⇔アデノシン6mg (改訂3版救急蘇生法の指針 2005 医療従事者用))

心血管における作用
SP.590

上室性不整脈 (GOO.917)
first drug for most forms of stable narrow-complex SVT. Effective to reentry involving AV node or sinus node. AF, AFL, VTは適応外。(Advanced Cardiovascular Life Support Provider manual ISBN 978-1-61669-010-6 p.165)

ACLS：アデノシン6mgを急速静注(1-3秒)、次いで生食を20ml入れる。その後、注射した肢を挙上。必要があれば2回目の投与は12mgを1-2分かけて静注。(Advanced Cardiovascular Life Support Provider manual ISBN 978-1-61669-010-6 p.165)
PALS：１回目　0.1mg/kgを急速静注/骨髄内投与(max 6mg)　２回目　0.2mg/kgをを急速静注/骨髄内投与(max 12mg)